Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
ITGAL VHH recombinant monoclonal antibody
ITGAV VHH recombinant monoclonal antibody
ITGB7 VHH recombinant monoclonal antibody
KIR3DL2 VHH recombinant monoclonal antibody
KLB VHH recombinant monoclonal antibody
KLRG1 VHH recombinant monoclonal antibody
L-Selectin VHH recombinant monoclonal antibody
LEPR VHH recombinant monoclonal antibody
LGALS3 VHH recombinant monoclonal antibody
LGR5 VHH recombinant monoclonal antibody
LIF VHH recombinant monoclonal antibody
LILRA4 VHH recombinant monoclonal antibody